Prevalence of Coronary Artery Disease in the Siblings of Premature Coronary Heart Disease
This study is currently recruiting participants.
Verified July 2012 by Yonsei University
Sponsor:
Yonsei University
Collaborator:
Korean Society of Lipidology and Atherosclerosis
Information provided by (Responsible Party):
Hyuk-Jae Chang, Yonsei University
ClinicalTrials.gov Identifier:
NCT00918242
First received: June 10, 2009
Last updated: July 20, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this prospective study is to investigate the prevalence of coronary artery disease using computed tomography with family history of premature coronary heart disease
| Condition |
|---|
|
Coronary Heart Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Assessment of Occult CAD: Premature CAD Sibling Study (PreCASS) |
Resource links provided by NLM:
Further study details as provided by Yonsei University:
Primary Outcome Measures:
- evaluation of prevalence to coronary artery disease using CT [ Time Frame: within 2 weeks from CT scanning ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 87 |
| Study Start Date: | June 2009 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital within 1 year
Criteria
Inclusion Criteria:
- within 1 year
- the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital
Exclusion Criteria:
- Documented coronary heart disease
- experienced adverse events with relevant treatment
- contraindicated with beta-blockers
- Any woman of childbearing potential who is pregnant, seeking to become pregnant or suspects
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00918242
Contacts
| Contact: Hyuk-Jae Chang, MD, PhD | 82-2-2228-8461 | hjchang@yuhs.ac |
Locations
| Korea, Republic of | |
| Yonsei University Severance Hospital | Recruiting |
| Seoul, Korea, Republic of, 102-752 | |
| Contact: Hyuk-Jae Chang, MD 82-2-2228-8454 hjchang@yuhs.ac | |
Sponsors and Collaborators
Yonsei University
Korean Society of Lipidology and Atherosclerosis
Investigators
| Principal Investigator: | Hyuk-Jae Chang, MD, PhD | Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine |
More Information
Publications:
| Responsible Party: | Hyuk-Jae Chang, Yonsei University |
| ClinicalTrials.gov Identifier: | NCT00918242 History of Changes |
| Other Study ID Numbers: | 20090616 |
| Study First Received: | June 10, 2009 |
| Last Updated: | July 20, 2012 |
| Health Authority: | Korea: Food and Drug Administration |
Keywords provided by Yonsei University:
|
Coronary Heart Disease computed tomography prevalence of coronary artery disease |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013